Additions of other cytokines such as granulocyte–macrophage colony-stimulating factor (GM-CSF) to this combination may result in a marked increase in the number of peripheral blood mononuclear cells (PBMCs) expressing co-stimulatory molecules and thus might be valuable for immunotherapy of RCC [59]. Here, CSF2 is linked to renal cell carcinoma.